Anjali Shukla

Anjali Shukla currently serves as Lead Interdisciplinary Scientist in the Office of Biotechnology Products, CDER, FDA with a focus on chemistry, manufacturing and control programs of biotechnology products at all stages of drug development. In the Office of Biotechnology Products, Anjali serves as subject matter expert for insulin products, and leads a product quality assessment team for biologic products, including biosimilars. Anjali also serves as FDA liaison to the USP Insulin Expert Panel. She also performs FDA pre-license inspections of drug manufacturing facilities. Prior to joining the FDA, Anjali was a Staff Scientist in the Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH. Anjali received her postdoctoral training also at the NCI.